VLCFA (VERY LONG CHAIN FATTY ACIDS) C22 TO C26 / EDTA PLASMA

image not found

NABL Cap Accredited    
This test measures very long chain fatty acids (C22–C26) in plasma to evaluate peroxisomal function. Metropolis Healthcare performs this analysis using highly sensitive instrumentation to help identify disorders such as X-linked adrenoleukodystrophy and other metabolic abnormalities. It is essential for diagnosing unexplained neurological, adrenal, or developmental symptoms. Results support early detection and management of peroxisomal disorders

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 16,050.00

Sample Type: / EDTA PLASMA

Fasting Not Required


Notes: F0012

Frequently Asked Questions (FAQ's):

What does the VLCFA test measure?
It measures C22–C26 long-chain fatty acids in plasma to assess peroxisomal metabolism.

Why is this test recommended?
It helps diagnose conditions like X-linked adrenoleukodystrophy and other peroxisomal disorders.

What sample is needed?
An EDTA plasma sample is required for this test.

Is fasting mandatory?
Fasting is preferred for optimal accuracy, but your doctor may guide based on clinical history.

How does Metropolis Healthcare perform this test?
Metropolis uses advanced mass spectrometry platforms for precise fatty-acid quantification.

What symptoms may lead to this test?
Neurological regression, adrenal dysfunction, seizures, or developmental delay may prompt testing.

Can medications affect the results?
Certain lipid-altering therapies may influence values; inform your doctor about ongoing medications.

How are abnormal results interpreted?
High VLCFA levels suggest impaired peroxisomal function and require specialist evaluation

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab